XML 94 R63.htm IDEA: XBRL DOCUMENT
v3.25.3

SHAREHOLDERS’ EQUITY (Details Narrative) |  |  |  |  |  |  |  |  |  |  | 12 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Aug. 25, 2025 $ / shares | Jul. 16, 2025 USD ($) $ / shares shares | Apr. 28, 2025 USD ($) $ / shares shares | Feb. 05, 2025 USD ($) $ / shares shares | Jan. 24, 2025 shares | Jan. 03, 2025 | Dec. 13, 2024 USD ($) $ / shares shares | Oct. 02, 2024 USD ($) $ / shares shares | Sep. 12, 2024 USD ($) $ / shares shares | May 17, 2024 USD ($) $ / shares shares | Jul. 31, 2025 USD ($) $ / shares shares | Jul. 31, 2024 USD ($) $ / shares shares | Aug. 01, 2025 shares | Apr. 12, 2021 $ / shares | Feb. 26, 2021 $ / shares
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares authorized |  |  |  |  |  |  |  |  |  |  |  | Unlimited |  | Unlimited |  |  |  |
Common stock, no par value | $ / shares |  |  |  |  |  |  |  |  |  |  |  | $ 0 |  | $ 0 |  |  |  |
Reverse stock split |  |  |  |  |  | 1-for-15 | 1-for-15 |  |  |  |  |  |  |  |  |  |  |
Common stock, shares outstanding |  |  |  |  |  | 294,694 |  |  |  |  |  | 1,883,906 |  | 121,907 |  |  |  |
Warrant offering price | $ / shares |  | $ 0.0067 |  |  |  |  |  |  |  |  |  | $ 7.50 |  | $ 112.50 |  |  | $ 588 | $ 510
Gross proceeds from warrant | $ |  |  |  |  |  |  |  |  |  |  |  | $ 50,900,000 |  |  |  |  |  |
Fair value adjustment of warrants | $ |  |  |  |  |  |  |  |  |  |  |  | (758,364) |  | $ (28,242,472) |  |  |  |
Gross proceeds from common shares | $ |  |  |  |  |  |  |  |  |  |  |  | 44,627,224 |  | 4,418,926 |  |  |  |
Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrant shares |  |  |  |  |  |  |  |  |  |  | 16,352 |  |  |  |  |  |  |
Fair value adjustment of warrants | $ |  |  |  |  |  |  |  |  |  |  | $ 2,020,207 | $ (758,364) | [1] | $ (28,242,472) | [1] |  |  |
Broker Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  | 156,130 |  |  |  |  | 247,800 |  |  |  |  |  |  |  |
Broker Warrants [Member] | Measurement Input, Share Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  | 50.40 |  |  |  |  | 94.50 |  |  |  |  |  |  |  |
Broker Warrants [Member] | Measurement Input, Exercise Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  | 50.00 |  |  |  |  | 129.40 |  |  |  |  |  |  |  |
Broker Warrants [Member] | Measurement Input, Expected Term [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expected life |  |  |  |  | 5 years |  |  |  |  | 5 years |  |  |  |  |  |  |  |
Broker Warrants [Member] | Measurement Input, Price Volatility [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  | 112 |  |  |  |  | 109 |  |  |  |  |  |  |  |
Broker Warrants [Member] | Measurement Input, Expected Dividend Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  | 0 |  |  |  |  | 0 |  |  |  |  |  |  |  |
Broker Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  | 4.37 |  |  |  |  | 3.469 |  |  |  |  |  |  |  |
Broker Warrants [Member] | Measurement Input Non Marketability Discount [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  |  | 16.38 |  |  |  |  |  |  |  |
Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrant shares |  |  |  |  |  |  |  | 2,466 | 1,709 |  |  |  |  |  |  |  |  |
Fair value adjustment of warrants | $ |  |  |  |  |  |  |  | $ 188,252 | $ 204,128 |  |  |  |  |  |  |  |  |
Placement Agent Warrants [Member] | Measurement Input, Share Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  | 99.00 | 151.50 |  |  |  |  |  |  |  |  |
Placement Agent Warrants [Member] | Measurement Input, Exercise Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  | 140.60 | 182.80 |  |  |  |  |  |  |  |  |
Placement Agent Warrants [Member] | Measurement Input, Expected Term [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expected life |  |  |  |  |  |  |  | 5 years | 5 years |  |  |  |  |  |  |  |  |
Placement Agent Warrants [Member] | Measurement Input, Price Volatility [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  | 111 | 112 |  |  |  |  |  |  |  |  |
Placement Agent Warrants [Member] | Measurement Input, Expected Dividend Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  | 0 | 0 |  |  |  |  |  |  |  |  |
Placement Agent Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  | 4.133 | 3.561 |  |  |  |  |  |  |  |  |
October 2024 Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrant shares |  |  |  |  |  |  |  |  | 34,190 |  |  |  |  |  |  |  |  |
Fair value adjustment of warrants | $ |  |  |  |  |  |  |  |  | $ 2,211,266 |  |  |  |  |  |  |  |  |
October 2024 Warrant [Member] | Measurement Input, Share Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  | 81.00 |  |  |  |  |  |  |  |  |
October 2024 Warrant [Member] | Measurement Input, Exercise Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  | 127.50 |  |  |  |  |  |  |  |  |
October 2024 Warrant [Member] | Measurement Input, Expected Term [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expected life |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |
October 2024 Warrant [Member] | Measurement Input, Price Volatility [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  | 121 |  |  |  |  |  |  |  |  |
October 2024 Warrant [Member] | Measurement Input, Expected Dividend Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |  |  |
October 2024 Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  | 3.553 |  |  |  |  |  |  |  |  |
April 2025 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrant shares |  |  |  | 306,666 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value adjustment of warrants | $ |  |  |  | $ 5,666,620 |  |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Warrants [Member] | Measurement Input, Share Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  | 26.50 |  |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Warrants [Member] | Measurement Input, Exercise Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  | 52.50 |  |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Warrants [Member] | Measurement Input, Expected Term [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expected life |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Warrants [Member] | Measurement Input, Price Volatility [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  | 105 |  |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Warrants [Member] | Measurement Input, Expected Dividend Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  | 0 |  |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  | 3.885 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | [2] |  |  |  |  |  |  |  |  |  |  | 1,560,034 |  | 15,352 |  |  |  |
July 2025 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrant shares |  |  | 1,200,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value adjustment of warrants | $ |  |  | $ 6,460,348 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2025 Warrants [Member] | Measurement Input, Share Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  | 7.10 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2025 Warrants [Member] | Measurement Input, Exercise Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  | 15.00 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2025 Warrants [Member] | Measurement Input, Expected Term [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expected life |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2025 Warrants [Member] | Measurement Input, Price Volatility [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  | 118 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2025 Warrants [Member] | Measurement Input, Expected Dividend Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  | 0 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2025 Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  | 3.99 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
October 2024 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant offering price | $ / shares |  |  |  |  |  |  |  |  |  |  |  | $ 127.50 |  |  |  |  |  |
Institutional Investors [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 300.00 |  |  |  |  |  |  |
Existing Investor And Director [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 332.25 |  |  |  |  |  |  |
May 2024 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued |  |  |  |  |  |  |  |  |  |  | 15,352 |  |  |  |  |  |  |
Number of securities called by warrants or rights |  |  |  |  |  |  |  |  |  |  | 666 |  |  |  |  |  |  |
Warrant offering price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 179.985 |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 0.015 |  |  |  |  |  |  |
Warrants expected life |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |
Number of warrant shares |  |  |  |  |  |  |  |  |  |  | 333 |  |  |  |  |  |  |
May 2024 Warrants [Member] | Measurement Input, Share Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  |  |  | 177.00 |  |  |  |  |  |  |
May 2024 Warrants [Member] | Measurement Input, Exercise Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  |  |  | 316.50 |  |  |  |  |  |  |
May 2024 Warrants [Member] | Measurement Input, Expected Term [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expected life |  |  |  |  |  |  |  |  |  |  | 5 years 6 months |  |  |  |  |  |  |
May 2024 Warrants [Member] | Measurement Input, Price Volatility [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  |  |  | 118 |  |  |  |  |  |  |
May 2024 Warrants [Member] | Measurement Input, Expected Dividend Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |
May 2024 Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  |  |  | 4.71 |  |  |  |  |  |  |
May 2024 Warrants [Member] | Measurement Input, Discount for Lack of Marketability [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  |  |  |  | 13.13 |  |  |  |  |  |  |
May 2024 Warrants [Member] | Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 316.50 |  |  |  |  |  |  |
May 2024 Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant to purchase, shares |  |  |  |  |  |  |  |  |  |  | 16,019 |  |  |  |  |  |  |
Gross proceeds from warrant | $ |  |  |  |  |  |  |  |  |  |  | $ 5,000,000.0 |  |  |  |  |  |  |
September 2024 Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  |  |  |  |  |  |  | $ 129.40 |  |  |  |  |  |  |  |
Warrants expected life |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |
Number of warrant shares |  |  |  |  |  |  |  |  |  | 4,108 |  |  |  |  |  |  |  |
Number of shares issued |  |  |  |  |  |  |  |  |  | 82,166 |  |  |  |  |  |  |  |
Sale of stock, price per share | $ / shares |  |  |  |  |  |  |  |  |  | $ 103.50 |  |  |  |  |  |  |  |
Gross proceeds from common shares | $ |  |  |  |  |  |  |  |  |  | $ 8,500,000 |  |  |  |  |  |  |  |
October 2024 Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of securities called by warrants or rights |  |  |  |  |  |  |  |  | 34,190 |  |  |  |  |  |  |  |  |
Gross proceeds from warrant | $ |  |  |  |  |  |  |  |  | $ 5,000,000 |  |  |  |  |  |  |  |  |
Number of shares issued |  |  |  |  |  |  |  |  | 34,190 |  |  |  |  |  |  |  |  |
October 2024 Offering [Member] | Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  |  |  |  |  |  | $ 182.80 |  |  |  |  |  |  |  |  |
Warrants expected life |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |
Number of warrant shares |  |  |  |  |  |  |  |  | 1,709 |  |  |  |  |  |  |  |  |
October 2024 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  |  |  |  |  |  | $ 127.50 |  |  |  |  |  |  |  |  |
Warrants expected life |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |
Sale of stock, price per share | $ / shares |  |  |  |  |  |  |  |  | $ 146.30 |  |  |  |  |  |  |  |  |
December 2024 Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of securities called by warrants or rights |  |  |  |  |  |  |  | 49,333 |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  |  |  |  |  | $ 140.60 |  |  |  |  |  |  |  |  |  |
Warrants expected life |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |
Number of warrant shares |  |  |  |  |  |  |  | 2,466 |  |  |  |  |  |  |  |  |  |
Number of shares issued |  |  |  |  |  |  |  | 49,333 |  |  |  |  |  |  |  |  |  |
Gross proceeds | $ |  |  |  |  |  |  |  | $ 5,550,000 |  |  |  |  |  |  |  |  |  |
December 2024 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  |  |  |  |  | $ 140.60 |  |  |  |  |  |  |  |  |  |
Sale of stock, price per share | $ / shares |  |  |  |  |  |  |  | $ 112.50 |  |  |  |  |  |  |  |  |  |
Exercisable warrants term |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |
December 2024 Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrant shares |  |  |  |  |  |  |  | 49,333 |  |  |  |  |  |  |  |  |  |
Fair value adjustment of warrants | $ |  |  |  |  |  |  |  | $ 2,327,089 |  |  |  |  |  |  |  |  |  |
December 2024 Warrant [Member] | Measurement Input, Share Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  | 66.00 |  |  |  |  |  |  |  |  |  |
December 2024 Warrant [Member] | Measurement Input, Exercise Price [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  | 140.60 |  |  |  |  |  |  |  |  |  |
December 2024 Warrant [Member] | Measurement Input, Expected Term [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expected life |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |
December 2024 Warrant [Member] | Measurement Input, Price Volatility [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  | 111 |  |  |  |  |  |  |  |  |  |
December 2024 Warrant [Member] | Measurement Input, Expected Dividend Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |  |  |  |
December 2024 Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding, measurement input |  |  |  |  |  |  |  | 4.133 |  |  |  |  |  |  |  |  |  |
February Two Thousand And Twenty Four Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant offering price | $ / shares |  |  |  |  | $ 40.00 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  |  | $ 50.00 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expected life |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrant shares |  |  |  |  | 3,812 |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued |  |  |  |  | 76,250 |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from common shares | $ |  |  |  |  | $ 3,050,000.00 |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  | $ 56.25 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from warrant | $ |  |  |  | $ 13,800,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expected life |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrant shares |  |  |  | 15,333 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued |  |  |  | 306,665 |  |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Offering [Member] | Regular Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued |  |  |  | 240,595 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of warrants traded |  |  |  | each consisting of one common share and one five-year publicly traded warrant |  |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Offering [Member] | Pre-Funded Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued |  |  |  | 66,070 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of warrants traded |  |  |  | each consisting of one pre-funded warrant (at a $0.001 strike) and one five-year publicly traded warrant |  |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Offering [Member] | Regular Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  | $ 45.00 |  |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Offering [Member] | Pre-Funded Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant offering price | $ / shares |  |  |  | 0.001 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  | 44.99 |  |  |  |  |  |  |  |  |  |  |  |  |  |
April 2025 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  |  | $ 52.50 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercisable warrants term |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2025 Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued |  |  | 1,200,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from warrant | $ |  |  | $ 15,000,000.0 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price | $ / shares |  |  | $ 12.50 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2025 Offering [Member] | Pre-Funded Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued |  |  | 122,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2025 Offering [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued |  |  | 1,077,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2025 Offering [Member] | Prefunded Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price | $ / shares |  |  | $ 12.49 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July 2025 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise price | $ / shares |  |  | $ 15.00 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercisable warrants term |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
October 2024 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued |  |  |  |  |  |  |  |  |  |  |  | 6,437 |  |  |  |  |  |
Gross proceeds from warrant | $ |  |  |  |  |  |  |  |  |  |  |  | $ 821,015 |  |  |  |  |  |
Subsequent Event [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subsidiary, Sale of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Reverse stock split |  | 1-for-10 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,883,906 |  |
Warrant offering price | $ / shares |  | $ 0.0067 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
[1] | Certain warrants were issued prior to August 1, 2022 in respect of public offerings and private placements that contain terms that require the warrants to be recorded as a liability at fair value under US GAAP. As a result, these warrants are valued at the end of each reporting period. For the year ended July 31, 2025, the Company recorded a gain on the revaluation of the total warrant liability of $758,364 in the consolidated statements of operations and comprehensive loss.
[2] | On January 24, 2025, the Company effected 1-for-15 reverse split of its issued and outstanding common shares and on August 25, 2025, the Company effected 1-for-10 reverse split of its issued and outstanding common shares, pursuant to which holders of the Company’s common shares received 0.0067 of a common share for every one common share (following both reverse share splits). All share, warrant, option and RSU amounts have been retroactively restated for all periods presented.

X
- Definition Description of warrants traded. + References No definition available. + Details
Name: | BCTX_DescriptionOnWarrantsTraded
Namespace Prefix: | BCTX_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercisable warrants term. + References No definition available. + Details
Name: | BCTX_ExercisableWarrantsTerm
Namespace Prefix: | BCTX_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Purchase price. + References No definition available. + Details
Name: | BCTX_PurchasePrice
Namespace Prefix: | BCTX_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount per share of no-par value common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockNoParValue
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Indicates whether number of common shares permitted to be issued is unlimited. Acceptable value is "Unlimited". + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesAuthorizedUnlimited
Namespace Prefix: | us-gaap_
Data Type: | us-types:authorizedUnlimitedItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 + Details
Name: | us-gaap_CommonStockSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 + Details
Name: | us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 + Details
Name: | us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor. + References No definition available. + Details
Name: | us-gaap_SaleOfStockConsiderationReceivedPerTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 4 -Subparagraph (SAB Topic 4.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4 + Details
Name: | us-gaap_StockholdersEquityReverseStockSplit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiarySaleOfStockLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_BrokerWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=BCTX_MeasurementInputNonMarketabilityDiscountMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_PlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_OctoberTwoThousandAndTwentyFourWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_AprilTwoThousandAndTwentyFiveWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_JulyTwoThousandAndTwentyFiveWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_OctoberTwoThousandTwentyFourWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=BCTX_InstitutionalInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=BCTX_ExistingInvestorAndDirectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_MayTwoThousandAndTwentyFourWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_MayTwoThousandAndTwentyFourOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_SeptemberTwoThousandAndTwentyFourOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_OctoberTwoThousandAndTwentyFourOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_OctoberTwoThousandAndTwentyFourWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_DecemberTwoThousandAndTwentyFourOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_DecemberTwoThousandAndTwentyFourWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_DecemberTwoThousandAndTwentyFourWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_FebruaryTwoThousandAndTwentyFourOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_AprilTwoThousandAndTwentyFiveOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_RegularWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_PreFundedWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_AprilThousandAndTwentyFiveOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_AprilTwoThousandAndTwentyFiveWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_JulyTwoThousandAndTwentyFiveOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_PrefundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_JulyTwoThousandAndTwentyFiveWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_OctoberTwoThousandTwentyFourWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |